Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
AstraZeneca
Moodys
Harvard Business School
McKinsey

Last Updated: August 17, 2022

Drugs in MeSH Category Antipruritics


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan LORATADINE loratadine TABLET;ORAL 075790-001 Nov 7, 2008 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Akorn KETOTIFEN FUMARATE ketotifen fumarate SOLUTION/DROPS;OPHTHALMIC 077958-001 Jul 26, 2007 OTC No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mylan PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride TABLET;ORAL 091054-001 Aug 30, 2011 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Watson Labs PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride TABLET;ORAL 083204-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Nesher Pharms ONDANSETRON ondansetron TABLET, ORALLY DISINTEGRATING;ORAL 077717-001 Jun 25, 2007 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Sun Pharm Inds Inc PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride TABLET;ORAL 040863-002 Dec 30, 2008 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Prinston Inc PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride TABLET;ORAL 040622-002 Jul 18, 2006 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Dow
Medtronic
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.